Medicine
Toprol XL 25 mg extended-release tablet
Toprol XL 25 mg extended-release tablet is a prescription medicine containing Metoprolol for oral use, marketed by Melinta Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F). Excursions permitted to 15-30°C (59-86°F).
Key facts
- Active ingredient (INN)
- Metoprolol
- Brand
- Toprol XL
- Strength
- 25 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 45 tablets, 90 tablets
- Marketing authorisation holder
- Melinta Therapeutics
- Manufacturers
- Melinta TherapeuticsAphena Pharma Solutions - Tennessee
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F). Excursions permitted to 15-30°C (59-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 January 2018
- Identifiers
- RxCUI 866427, 866429, 866412 +5DailyMed set ID a07891a5-152e-4a38-8179-e05a90458a7d, 496ddfaa-7c9c-4888-b747-a210249b367aNDC 71610-035, 70842-110Application NDA019962
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 bottle | 70842-110-02 | Melinta Therapeutics | 3 July 2023 |
| 45 tablet, extended release in 1 bottle | 71610-035-45 | Aphena Pharma Solutions - Tennessee | 26 January 2018 |
| 90 tablet, extended release in 1 bottle | 71610-035-60 | Aphena Pharma Solutions - Tennessee | 26 January 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 7 August 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Metoprolol 25 mg extended-release tablet.
Other strengths and forms of Metoprolol
Clinical summary
Metoprolol is a beta-adrenergic blocker indicated for the treatment of hypertension, to lower blood pressure, among other approved uses. It is available as extended-release tablets, tablets and injection for oral and intravenous use. MedsAcross supplies Metoprolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MetoprololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lopressor prescribing information (Validus Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Toprol XL 25 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.